je.st
news
Tag: nps
Shire to buy NPS for $5.2 billion
2015-01-12 02:38:40| Biotech - Topix.net
Yet another major pharmaceutical deal has hit Wall Street. Shire Plc, an Irish-based drugmaker, has agreed to acquire New Jersey-based NPS Pharmaceuticals for about $5.2 billion in an effort to bolster its Shire to buy NPS for $5.2 billion Yet another major pharmaceutical deal has hit Wall Street.
Shire to buy New Jersey-based NPS Pharma is $5.2B deal
2015-01-11 19:19:23| Biotech - Topix.net
Less than two months after announcing its U.S. headquarters will be in Massachusetts, Shire Pharmaceuticals is buying a New Jersey-based maker of gastrointestinal drugs, NPS Pharma for $5.2 billion. The purchase price represents a 51 percent premium to the share price of NPS when reports of the pending deal first emerged on Dec. 16, and is 9 percent higher than it's stock as of Friday's close.
Shire said to consider bid for NPS as it revisits takeovers
2014-12-21 12:49:42| Biotech - Topix.net
A Shire logo sits on a sign outside office buildings at Shire Plc's site in Chineham, U.K. Shire is based for tax purposes in Ireland. Chief Executive Officer Flemming Ornskov and other top executives work in Lexington, Mass.
EZchip Highlights NPS Opportunities in Emerging White Box Networking
2014-04-29 06:00:00| Industrial Newsroom - All News for Today
YOKNEAM, Israel -<br /> <br /> EZchip Semiconductor Ltd. (NASDAQ:EZCH), a leader in high-performance network processors, is highlighting new opportunities for its NPS, Network Processors for Smart networks, brought about through powerful new trends in the networking market. EZchip's NPS, already publicized as providing distinct performance acceleration for SDN and NFV networks (for details visit <a href="http://www.ezchip.com">http://www.ezchip.com</a>) is now also gaining momentum as the ...This story is related to the following:Mechanical Components and AssembliesSearch for suppliers of: Central Processing Unit (CPU), Intellectual Property (IP), Microprocessor & Processor Cores
Tags: box
white
opportunities
networking
NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe
2014-01-04 07:51:40| Biotech - Topix.net
NPS Pharmaceuticals, Inc. , a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism.
Tags: europe
drug
receives
designation
Sites : [1] [2]